FdaApplication

ANDA 211040

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNOVITIUM PHARMA LLC
application_typeANDA
approval_date2019-01-28

Products (1)

ProductActive ingredientStrengthDosage form
SIROLIMUSSIROLIMUS1MG/MLSOLUTION;ORAL

1 product